Control of nausea with palonosetron versus granisetron, both combined with dexamethasone, in patients receiving cisplatin- or anthracycline plus cyclophosphamide-based regimens

Benzer Materyaller

• A double‐blind, randomized, multicenter phase 3 study of palonosetron vs granisetron combined with dexamethasone and fosaprepitant to prevent chemotherapy‐induced nausea and vomiting in patients with breast cancer receiving anthracycline and cyclophosphamide
  Yazar:: Matsumoto, Koji, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Olanzapine plus aprepitant, palonosetron, and dexamethasone for nausea and vomiting in patients with breast cancer receiving anthracycline: A retrospective study
  Yazar:: Kawazoe, Hitoshi, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Postoperative Nausea and Vomiting: Palonosetron with Dexamethasone vs. Ondansetron with Dexamethasone in Laparoscopic Hysterectomies
  Yazar:: Sharma, Anish N. G., ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Antiemetic efficacy and safety of granisetron or palonosetron alone and in combination with a corticosteroid for ABVD therapy-induced nausea and vomiting
  Yazar:: Mayako Uchida, ve diğerleri
  Baskı/Yayın Bilgisi: (2018-01-01)
• Antiemetic efficacy and safety of granisetron or palonosetron alone and in combination with a corticosteroid for ABVD therapy-induced nausea and vomiting
  Yazar:: Uchida, Mayako, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)